| - GRCh37:
- Chr10:112021329-113054313
| ADRA2A, BBIP1, DUSP5, MXI1, PDCD4, RBM20, SHOC2, SMC3, SMNDC1 | | RASopathy | Uncertain significance (Jan 23, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr12:25398299
- GRCh38:
- Chr12:25245365
| KRAS | V7E | RASopathy | Likely pathogenic (Apr 3, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr7:140549891
- GRCh38:
- Chr7:140850091
| BRAF | | RASopathy | Likely benign (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:4077097-4123872
| MAP2K2 | | RASopathy | Uncertain significance (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:4094110-4102471
| MAP2K2 | | RASopathy | Uncertain significance (Aug 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:4090596-4090726
| MAP2K2 | | RASopathy | Uncertain significance (May 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:4123761-4123872
| MAP2K2 | | RASopathy | Uncertain significance (Jan 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:37334416-39347563
| ARHGEF33, ATL2, CDC42EP3, CEBPZ, CYP1B1, DHX57, EIF2AK2, GALM, GEMIN6, HNRNPLL, MORN2, NDUFAF7, PRKD3, QPCT, RMDN2, SOS1, SOS1-IT1, SRSF7, SULT6B1 | | RASopathy | Pathogenic (Aug 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:39212965-39251298
| SOS1, SOS1-IT1 | | RASopathy | Uncertain significance (Jun 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:118967708-119103425
| ABCG4, C2CD2L, CBL, CCDC153, DPAGT1, HINFP, NHERF4, NLRX1 | | RASopathy | Uncertain significance (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:119077128-119077342
| CBL | | RASopathy | Uncertain significance (Oct 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:119144558-119156296
| CBL | | RASopathy | Uncertain significance (Nov 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:119077128-119077342
| CBL | | RASopathy | Uncertain significance (Mar 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:25362729-25362865
| KRAS | | RASopathy | Uncertain significance (Nov 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr12:25398188-25398318
| KRAS | | RASopathy | Uncertain significance (Oct 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr7:138391369-141759786
| ADCK2, AGK, ATP6V0A4, BRAF, CLEC2L, CLEC5A, DENND11, DENND2A, FMC1, FMC1-LUC7L2, IFT56, KDM7A, KIAA1549, KLRG2, LUC7L2, MGAM, MKRN1, MRPS33, NDUFB2, OR9A4, PARP12, PRSS37, RAB19, SLC37A3, SSBP1, TAS2R3, TAS2R38, TAS2R4, TAS2R5, TBXAS1, TMEM178B, TMEM213, UBN2, WEE2, ZC3HAV1, ZC3HAV1L | | not provided | Pathogenic (Apr 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr7:140624346-140624503
| BRAF | | RASopathy | Uncertain significance (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr7:140534389-140534692
| BRAF | | RASopathy | Uncertain significance (Jan 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:12645615-12660220
| RAF1 | | RASopathy | Uncertain significance (Oct 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:12650245-12660220
| RAF1 | | RASopathy | Uncertain significance (Oct 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:12629070-12660220
| RAF1 | | RASopathy | Uncertain significance (Jul 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:12558090-12629156
| MKRN2, RAF1, TSEN2 | | RASopathy | Uncertain significance (Sep 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:112909300-112915437
| PTPN11 | | RASopathy | Pathogenic (Jun 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:112910728-113008334
| PTPN11 | | RASopathy | Uncertain significance (Jun 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:112884060-112884222
| PTPN11 | | RASopathy | Uncertain significance (Jul 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:112919858-112920029
| PTPN11 | | RASopathy | Uncertain significance (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679686-66679785
| MAP2K1 | | RASopathy | Uncertain significance (Jan 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:113456513-116311162
| SIKE1, DENND2C, AP4B1, NGF, PHTF1, OLFML3, SYCP1, LRIG2, DCLRE1B, AMPD1, SYT6, TSPAN2, PTPN22, TSHB, CSDE1, MAGI3, SLC16A1, BCAS2, CASQ2, RSBN1, NRAS, BCL2L15, TRIM33, HIPK1, VANGL1 | | RASopathy | Uncertain significance (Feb 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:112891153
- GRCh38:
- Chr12:112453349
| PTPN11 | G162C, G163C | RASopathy | Uncertain significance (Sep 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:119156280
- GRCh38:
- Chr11:119285570
| CBL | | RASopathy | Uncertain significance (Nov 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:116691583-121500272
| ABCG4, APOA1, APOA4, APOC3, ARCN1, ARHGEF12, ATP5MG, BACE1, BACE1-AS, BCL9L, C1QTNF5, C2CD2L, CBL, CCDC153, CD3D, CD3E, CD3G, CENATAC, CEP164, CXCR5, DDX6, DPAGT1, DSCAML1, FOXR1, FXYD2, FXYD6, FXYD6-FXYD2, GRIK4, H2AX, HINFP, HMBS, HYOU1, IFT46, IL10RA, JAML, KMT2A, MCAM, MFRP, MPZL2, MPZL3, NECTIN1, NHERF4, NLRX1, OAF, PAFAH1B2, PCSK7, PHLDB1, POU2F3, RNF214, RNF26, RPS25, SC5D, SCN2B, SCN4B, SIDT2, SIK3, SLC37A4, SORL1, TAGLN, TBCEL, TECTA, THY1, TLCD5, TMEM25, TMPRSS13, TMPRSS4, TRAPPC4, TREH, TRIM29, TTC36, UBE4A, UPK2, USP2, VPS11 | | Inflammatory bowel disease 28, Isolated microphthalmia 5, Immunodeficiency 19, RASopathy, Combined immunodeficiency due to CD3gamma deficiency, Immunodeficiency 18
| Uncertain significance (Sep 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:119155931
- GRCh38:
- Chr11:119285221
| CBL | | RASopathy | Likely benign (May 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:112724678
- GRCh38:
- Chr10:110964920
| SHOC2 | V188M | RASopathy | Uncertain significance (Mar 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:119168095
- GRCh38:
- Chr11:119297385
| CBL | A719S | RASopathy | Uncertain significance (Oct 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:39224538
- GRCh38:
- Chr2:38997397
| SOS1 | | RASopathy | Likely benign (Oct 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:119155824
- GRCh38:
- Chr11:119285114
| CBL | | RASopathy | Likely benign (Feb 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727499
- GRCh38:
- Chr15:66435161
| MAP2K1 | S50N, S72N | RASopathy | Uncertain significance (Jul 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:112924451
- GRCh38:
- Chr12:112486647
| PTPN11 | | RASopathy | Likely benign (Aug 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727588-66727590
- GRCh38:
- Chr15:66435250-66435252
| MAP2K1 | | RASopathy | Likely benign (Feb 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66679762
- GRCh38:
- Chr15:66387424
| MAP2K1 | A26V | RASopathy | Uncertain significance (Oct 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:112915651
- GRCh38:
- Chr12:112477847
| PTPN11 | | RASopathy | Likely benign (Sep 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:12629144
- GRCh38:
- Chr3:12587645
| RAF1 | | RASopathy | Likely benign (Sep 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:39216403
- GRCh38:
- Chr2:38989262
| SOS1 | | RASopathy | Likely benign (Jun 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:39222285
- GRCh38:
- Chr2:38995144
| SOS1 | H1102Y, H1109Y | RASopathy | Likely benign (Jun 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:12660108
- GRCh38:
- Chr3:12618609
| RAF1 | Y38C | RASopathy | Likely benign (Mar 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr7:140534625
- GRCh38:
- Chr7:140834825
| BRAF | | not provided, RASopathy | Likely benign (Jan 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:119158600
- GRCh38:
- Chr11:119287890
| CBL | | RASopathy | Likely benign (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:119148922
- GRCh38:
- Chr11:119278212
| CBL | C381Y | RASopathy | Uncertain significance (Jan 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:4099217
- GRCh38:
- Chr19:4099219
| MAP2K2 | P301A | RASopathy | Uncertain significance (Jul 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:12632282
- GRCh38:
- Chr3:12590783
| RAF1 | | RASopathy | Likely benign (Jan 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66779642
- GRCh38:
- Chr15:66487304
| MAP2K1 | | RASopathy | Likely benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr7:140507875
- GRCh38:
- Chr7:140808075
| BRAF | | RASopathy | Likely benign (Oct 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:39224409
- GRCh38:
- Chr2:38997268
| SOS1 | | RASopathy | Likely benign (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:119077153
- GRCh38:
- Chr11:119206443
| CBL, LOC130006895 | S9F | RASopathy | Uncertain significance (Sep 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:119155751
- GRCh38:
- Chr11:119285041
| CBL | L502F | CBL-related condition, RASopathy | Uncertain significance (Sep 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:4117552
- GRCh38:
- Chr19:4117554
| MAP2K2 | | RASopathy | Likely benign (Mar 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:39234255
- GRCh38:
- Chr2:39007114
| SOS1 | E857K, E864K | RASopathy | Uncertain significance (Jun 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr7:140476867
- GRCh38:
- Chr7:140777067
| BRAF | | RASopathy | Likely benign (May 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:39214685
- GRCh38:
- Chr2:38987544
| SOS1 | V1140M, V1147M, V1132M | RASopathy | Uncertain significance (Aug 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:112915837
- GRCh38:
- Chr12:112478033
| PTPN11 | | RASopathy | Likely benign (Oct 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:119168112
- GRCh38:
- Chr11:119297402
| CBL | | RASopathy | Likely benign (Feb 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727352
- GRCh38:
- Chr15:66435014
| MAP2K1 | | RASopathy | Likely benign (Oct 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:12641932
- GRCh38:
- Chr3:12600433
| RAF1 | | RASopathy | Likely benign (Sep 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr7:140534567
- GRCh38:
- Chr7:140834767
| BRAF | S64A, S82A, S116A | RASopathy | Uncertain significance (Jul 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:4117441
- GRCh38:
- Chr19:4117443
| MAP2K2 | | RASopathy | Likely benign (Jan 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:119167656
- GRCh38:
- Chr11:119296946
| CBL | G689W | RASopathy | Uncertain significance (Oct 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:4117527
- GRCh38:
- Chr19:4117529
| MAP2K2 | G65S | RASopathy | Uncertain significance (Jun 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:112769606
- GRCh38:
- Chr10:111009848
| SHOC2 | | RASopathy | Likely benign (Jun 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:39213383
- GRCh38:
- Chr2:38986242
| SOS1 | R1188Q, R1195Q, R1180Q | RASopathy | Uncertain significance (Oct 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:119167612
- GRCh38:
- Chr11:119296902
| CBL | | RASopathy | Likely benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:112939957
- GRCh38:
- Chr12:112502153
| PTPN11 | | RASopathy | Likely benign (Apr 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:119144742
- GRCh38:
- Chr11:119274032
| CBL | | not specified, RASopathy | Conflicting interpretations of pathogenicity (Feb 20, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:12626623
- GRCh38:
- Chr3:12585124
| RAF1 | Q442E, Q475E, Q495E, Q523E, Q556E, Q576E | RASopathy | Uncertain significance (May 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:112724245
- GRCh38:
- Chr10:110964487
| SHOC2 | | RASopathy | Likely benign (May 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:112724242
- GRCh38:
- Chr10:110964484
| SHOC2 | E42D | RASopathy | Uncertain significance (Dec 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr7:140434564
- GRCh38:
- Chr7:140734764
| BRAF | A690S, A752S, A712S, A660S, A675S, A715S, A624S, A678S | RASopathy | Uncertain significance (Jul 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:4090687
- GRCh38:
- Chr19:4090689
| MAP2K2 | R371L | RASopathy | Uncertain significance (Feb 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:115251293-115251294
- GRCh38:
- Chr1:114708672-114708673
| NRAS | | RASopathy | Benign (Apr 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:12645625
- GRCh38:
- Chr3:12604126
| RAF1 | | RASopathy | Likely benign (Jun 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr7:140439755-140439756
- GRCh38:
- Chr7:140739955-140739956
| BRAF | | RASopathy | Benign (Oct 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:39249771
- GRCh38:
- Chr2:39022630
| SOS1 | I593V, I600V | Cardiovascular phenotype, RASopathy | Uncertain significance (May 11, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:140439601
- GRCh38:
- Chr7:140739801
| BRAF | | RASopathy | Likely benign (Feb 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:112915513
- GRCh38:
- Chr12:112477709
| PTPN11 | | RASopathy | Likely benign (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:39251186
- GRCh38:
- Chr2:39024045
| SOS1 | | Cardiovascular phenotype, RASopathy | Likely benign (May 14, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:119103418
- GRCh38:
- Chr11:119232708
| CBL | | RASopathy | Likely benign (Oct 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66782063
- GRCh38:
- Chr15:66489725
| MAP2K1 | K344Q, K296Q | RASopathy | Uncertain significance (Apr 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66777358
- GRCh38:
- Chr15:66485020
| MAP2K1 | V194M, V242M | RASopathy | Uncertain significance (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:4099229
- GRCh38:
- Chr19:4099231
| MAP2K2 | | RASopathy | Likely benign (May 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:4099214
- GRCh38:
- Chr19:4099216
| MAP2K2 | G302R | RASopathy | Uncertain significance (Aug 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:119169125
- GRCh38:
- Chr11:119298415
| CBL | E770G | RASopathy | Uncertain significance (Mar 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:119149248
- GRCh38:
- Chr11:119278538
| CBL | C419Y | RASopathy | Uncertain significance (Jan 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:39249754
- GRCh38:
- Chr2:39022613
| SOS1 | | Cardiovascular phenotype, RASopathy | Likely benign (Mar 23, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:112915478
- GRCh38:
- Chr12:112477674
| PTPN11 | H292Y, H293Y | RASopathy | Uncertain significance (Jun 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66735610
- GRCh38:
- Chr15:66443272
| MAP2K1 | | RASopathy | Likely benign (Mar 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:112891166
- GRCh38:
- Chr12:112453362
| PTPN11 | V167A, V166A | RASopathy | Uncertain significance (Jul 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:4101222
- GRCh38:
- Chr19:4101224
| MAP2K2 | | RASopathy | Uncertain significance (Aug 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:25398253
- GRCh38:
- Chr12:25245319
| KRAS | | RASopathy | Likely benign (Jun 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr7:140487337
- GRCh38:
- Chr7:140787537
| BRAF | | RASopathy | Likely benign (May 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:12641873
- GRCh38:
- Chr3:12600374
| RAF1 | | RASopathy | Likely benign (Jul 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:119145524
- GRCh38:
- Chr11:119274814
| CBL | | RASopathy | Likely benign (Aug 27, 2022) | criteria provided, single submitter |